Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Halak Brian K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   28    
Direct Shares   10,552,431    

Indirect Shares

   959,812      
Direct Value   $74,926,074    

Indirect Value

   $10,163,779      
Total Shares   11,512,243      
Total Value   $85,089,852      


Volcano Corp $0 Orexigen Therapeutics, Inc. $24 Vanda Pharmaceuticals Inc. $39,872 Esperion Therapeutics, Inc. $5,231,967 Evoke Pharma Inc $281,922 Veracyte, Inc. $63,224,167 Dicerna Pharmaceuticals Inc $983,401 Otonomy, Inc. $0 Atara Biotherapeutics, Inc. $9,693 Evofem Biosciences Inc $3,091,643 aTyr Pharma Inc $4,915 Glaukos Corp $713,745 Alimera Sciences Inc $100 Syndax Pharmaceuticals Inc $114,456 ReShape Lifesciences Inc $93,626 Bionano Genomics, Inc $1,076,021 Alliqua BioMedical Inc $60,523 Volcano Corp $0 Orexigen Therapeutics, Inc. $24 Vanda Pharmaceuticals Inc. $39,872 Esperion Therapeutics, Inc. $5,231,967 Evoke Pharma Inc $281,922 Veracyte, Inc. $63,224,167 Dicerna Pharmaceuticals Inc $983,401 Otonomy, Inc. $0 Atara Biotherapeutics, Inc. $9,693 Evofem Biosciences Inc $3,091,643 aTyr Pharma Inc $4,915 Glaukos Corp $713,745 Alimera Sciences Inc $100 Syndax Pharmaceuticals Inc $114,456 ReShape Lifesciences Inc $93,626 Bionano Genomics, Inc $1,076,021 Alliqua BioMedical Inc $60,523
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Northstar Neuroscience Inc NSTR Director 0 2006-05-04 3,333    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 3,415 2008-04-24 56,718    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 4,529 2011-12-22 50,643    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2006-05-09 100,355    Premium*  
            Vanda Pharmaceuticals Inc. VNDA Director 2010-03-26 7,276 2010-03-26 0    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2014-11-17 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2015-03-20 2,216,935 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2017-12-11 0 2013-07-15 55,296    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 2016-11-01 0 2013-08-21 17,171    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 2016-05-26 606,283 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2014-09-10 2,763,294 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA Director 2017-12-18 25,730 2018-11-06 19,150    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Otonomy, Inc. OTIC 10% Owner 2014-08-18 11,715 2014-08-18 0    Premium*  
            Atara Biotherapeutics, Inc. ATRA 10% Owner 2014-10-21 15,890 2014-10-21 0    Premium*  
            Evofem Biosciences Inc EVFM 10% Owner 2014-11-25 3,091,643 2014-11-25 0    Premium*  
            aTyr Pharma Inc LIFE 10% Owner 2015-05-12 13,414 2015-05-12 0    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 6,501 2015-06-30 0    Premium*  
            Alimera Sciences Inc ALIM Director 2021-09-17 327 2015-07-16 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 10% Owner 2016-03-08 5,641 2016-03-08 0    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2019-08-06 813,433 2016-10-12 0    Premium*  
            Bionano Genomics, Inc BNGO 10% Owner 2018-08-23 943,878 2018-08-23 0    Premium*  
            Alliqua BioMedical Inc ALQA 10% Owner 2019-05-03 22,527 0    Premium*  
* Premium Members only  

Records found :    152         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2015-04-16 4 S $7.07 $229,146 D/D (32,411) 1,064,164 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2015-08-18 4 S $7.02 $1,418 D/D (202) 17,947 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2015-08-18 4 S $7.02 $83,089 D/D (11,836) 1,052,328 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-06 4 S $5.22 $773 D/D (148) 17,799 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-06 4 S $5.22 $45,252 D/D (8,669) 1,043,659 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-07 4 S $5.26 $2,499 D/D (475) 17,324 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-07 4 S $5.26 $146,128 D/D (27,781) 1,015,878 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-08 4 S $5.35 $1,343 D/D (251) 17,073 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-08 4 S $5.35 $77,864 D/D (14,554) 1,001,324 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-11 4 S $5.22 $392 D/D (75) 16,998 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-11 4 S $5.22 $22,697 D/D (4,348) 996,976 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-19 4 S $5.36 $198,609 D/D (37,054) 959,922 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-19 4 S $5.36 $3,388 D/D (632) 16,366 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-20 4 S $5.29 $402 D/D (76) 16,290 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-20 4 S $5.29 $23,403 D/D (4,424) 955,498 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-25 4 S $5.20 $7,758 D/D (1,492) 954,006 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-25 4 S $5.20 $109 D/D (21) 16,269 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-27 4 S $5.02 $18,087 D/D (3,603) 950,403 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-04-27 4 S $5.02 $306 D/D (61) 16,208 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-05-26 4 S $4.70 $1,617,364 D/D (344,120) 606,283 0 -
EVOK Evoke Pharma Inc 10% Owner   –       –       •   2016-05-26 4 S $4.70 $27,636 D/D (5,880) 10,328 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-10-30 4 S $13.68 $3,410,619 I/I (245,096) 23,996 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-10-31 4 S $13.60 $1,762,954 I/I (129,629) 23,037 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-11-01 4 S $13.37 $2,534,618 I/I (189,575) 21,629 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2018-11-02 4 S $13.47 $2,569,685 I/I (190,771) 20,217 0 -
  152  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us